nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—CYP3A4—Rivastigmine—Alzheimer's disease	0.131	0.432	CbGbCtD
Canagliflozin—CYP3A4—Donepezil—Alzheimer's disease	0.105	0.345	CbGbCtD
Canagliflozin—CYP3A4—Galantamine—Alzheimer's disease	0.0674	0.223	CbGbCtD
Canagliflozin—Polydipsia—Donepezil—Alzheimer's disease	0.0137	0.0303	CcSEcCtD
Canagliflozin—Sunburn—Rivastigmine—Alzheimer's disease	0.0125	0.0276	CcSEcCtD
Canagliflozin—Polydipsia—Memantine—Alzheimer's disease	0.0124	0.0275	CcSEcCtD
Canagliflozin—Micturition urgency—Donepezil—Alzheimer's disease	0.00747	0.0165	CcSEcCtD
Canagliflozin—Fracture—Donepezil—Alzheimer's disease	0.00729	0.0162	CcSEcCtD
Canagliflozin—Multiple fractures—Donepezil—Alzheimer's disease	0.00729	0.0162	CcSEcCtD
Canagliflozin—Micturition urgency—Rivastigmine—Alzheimer's disease	0.00663	0.0147	CcSEcCtD
Canagliflozin—Multiple fractures—Memantine—Alzheimer's disease	0.00662	0.0147	CcSEcCtD
Canagliflozin—Fracture—Memantine—Alzheimer's disease	0.00662	0.0147	CcSEcCtD
Canagliflozin—Fracture—Rivastigmine—Alzheimer's disease	0.00647	0.0144	CcSEcCtD
Canagliflozin—Multiple fractures—Rivastigmine—Alzheimer's disease	0.00647	0.0144	CcSEcCtD
Canagliflozin—Nocturia—Galantamine—Alzheimer's disease	0.00589	0.0131	CcSEcCtD
Canagliflozin—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00534	0.0118	CcSEcCtD
Canagliflozin—Rash pustular—Donepezil—Alzheimer's disease	0.00531	0.0118	CcSEcCtD
Canagliflozin—Cystitis—Galantamine—Alzheimer's disease	0.00528	0.0117	CcSEcCtD
Canagliflozin—Blood urea increased—Galantamine—Alzheimer's disease	0.00516	0.0114	CcSEcCtD
Canagliflozin—Rash erythematous—Memantine—Alzheimer's disease	0.00502	0.0111	CcSEcCtD
Canagliflozin—Dapagliflozin—CYP2D6—Alzheimer's disease	0.00496	1	CrCbGaD
Canagliflozin—Bladder pain—Galantamine—Alzheimer's disease	0.00494	0.011	CcSEcCtD
Canagliflozin—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00491	0.0109	CcSEcCtD
Canagliflozin—Nocturia—Donepezil—Alzheimer's disease	0.00457	0.0101	CcSEcCtD
Canagliflozin—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00414	0.00917	CcSEcCtD
Canagliflozin—Cystitis—Donepezil—Alzheimer's disease	0.00409	0.00907	CcSEcCtD
Canagliflozin—Nocturia—Rivastigmine—Alzheimer's disease	0.00406	0.00899	CcSEcCtD
Canagliflozin—Blood urea increased—Donepezil—Alzheimer's disease	0.004	0.00886	CcSEcCtD
Canagliflozin—Vaginal infection—Donepezil—Alzheimer's disease	0.004	0.00886	CcSEcCtD
Canagliflozin—Bladder pain—Donepezil—Alzheimer's disease	0.00383	0.00849	CcSEcCtD
Canagliflozin—Hyperkalaemia—Memantine—Alzheimer's disease	0.00378	0.00838	CcSEcCtD
Canagliflozin—Cystitis noninfective—Memantine—Alzheimer's disease	0.00376	0.00833	CcSEcCtD
Canagliflozin—Cystitis—Memantine—Alzheimer's disease	0.00371	0.00823	CcSEcCtD
Canagliflozin—Dehydration—Galantamine—Alzheimer's disease	0.00369	0.00818	CcSEcCtD
Canagliflozin—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00368	0.00815	CcSEcCtD
Canagliflozin—Cystitis—Rivastigmine—Alzheimer's disease	0.00363	0.00805	CcSEcCtD
Canagliflozin—Blood urea increased—Memantine—Alzheimer's disease	0.00363	0.00805	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00362	0.00803	CcSEcCtD
Canagliflozin—Vaginal infection—Rivastigmine—Alzheimer's disease	0.00355	0.00787	CcSEcCtD
Canagliflozin—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00354	0.00784	CcSEcCtD
Canagliflozin—Bladder pain—Memantine—Alzheimer's disease	0.00348	0.00771	CcSEcCtD
Canagliflozin—Urine output increased—Memantine—Alzheimer's disease	0.00348	0.00771	CcSEcCtD
Canagliflozin—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.00342	0.00758	CcSEcCtD
Canagliflozin—Urine output increased—Rivastigmine—Alzheimer's disease	0.0034	0.00754	CcSEcCtD
Canagliflozin—Bladder pain—Rivastigmine—Alzheimer's disease	0.0034	0.00754	CcSEcCtD
Canagliflozin—Thirst—Donepezil—Alzheimer's disease	0.00323	0.00716	CcSEcCtD
Canagliflozin—Diabetes mellitus—Memantine—Alzheimer's disease	0.00321	0.00711	CcSEcCtD
Canagliflozin—Polyuria—Memantine—Alzheimer's disease	0.00318	0.00705	CcSEcCtD
Canagliflozin—Pollakiuria—Galantamine—Alzheimer's disease	0.00317	0.00702	CcSEcCtD
Canagliflozin—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00315	0.00698	CcSEcCtD
Canagliflozin—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00314	0.00696	CcSEcCtD
Canagliflozin—Polyuria—Rivastigmine—Alzheimer's disease	0.00311	0.00689	CcSEcCtD
Canagliflozin—Renal failure acute—Memantine—Alzheimer's disease	0.00302	0.0067	CcSEcCtD
Canagliflozin—Urinary tract infection—Galantamine—Alzheimer's disease	0.00297	0.00659	CcSEcCtD
Canagliflozin—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00296	0.00656	CcSEcCtD
Canagliflozin—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00288	0.00639	CcSEcCtD
Canagliflozin—Thirst—Rivastigmine—Alzheimer's disease	0.00287	0.00636	CcSEcCtD
Canagliflozin—Hypoglycaemia—Memantine—Alzheimer's disease	0.00286	0.00634	CcSEcCtD
Canagliflozin—Dehydration—Donepezil—Alzheimer's disease	0.00286	0.00634	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00281	0.00623	CcSEcCtD
Canagliflozin—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.0028	0.0062	CcSEcCtD
Canagliflozin—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00271	0.00601	CcSEcCtD
Canagliflozin—Urethral disorder—Galantamine—Alzheimer's disease	0.00269	0.00596	CcSEcCtD
Canagliflozin—Blood creatinine increased—Memantine—Alzheimer's disease	0.00262	0.0058	CcSEcCtD
Canagliflozin—Pancreatitis—Donepezil—Alzheimer's disease	0.00261	0.00578	CcSEcCtD
Canagliflozin—Dehydration—Memantine—Alzheimer's disease	0.0026	0.00576	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00255	0.00565	CcSEcCtD
Canagliflozin—Dehydration—Rivastigmine—Alzheimer's disease	0.00254	0.00563	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00249	0.00553	CcSEcCtD
Canagliflozin—Angiopathy—Galantamine—Alzheimer's disease	0.00249	0.00552	CcSEcCtD
Canagliflozin—Breast disorder—Rivastigmine—Alzheimer's disease	0.00247	0.00547	CcSEcCtD
Canagliflozin—Pollakiuria—Donepezil—Alzheimer's disease	0.00246	0.00544	CcSEcCtD
Canagliflozin—Malnutrition—Galantamine—Alzheimer's disease	0.00239	0.0053	CcSEcCtD
Canagliflozin—Pancreatitis—Memantine—Alzheimer's disease	0.00237	0.00524	CcSEcCtD
Canagliflozin—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00231	0.00513	CcSEcCtD
Canagliflozin—Urinary tract infection—Donepezil—Alzheimer's disease	0.0023	0.00511	CcSEcCtD
Canagliflozin—Pollakiuria—Memantine—Alzheimer's disease	0.00223	0.00494	CcSEcCtD
Canagliflozin—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00218	0.00483	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00215	0.00478	CcSEcCtD
Canagliflozin—Syncope—Galantamine—Alzheimer's disease	0.00214	0.00475	CcSEcCtD
Canagliflozin—Urinary tract disorder—Donepezil—Alzheimer's disease	0.0021	0.00466	CcSEcCtD
Canagliflozin—Loss of consciousness—Galantamine—Alzheimer's disease	0.0021	0.00466	CcSEcCtD
Canagliflozin—Urinary tract infection—Memantine—Alzheimer's disease	0.00209	0.00464	CcSEcCtD
Canagliflozin—Urethral disorder—Donepezil—Alzheimer's disease	0.00209	0.00462	CcSEcCtD
Canagliflozin—Convulsion—Galantamine—Alzheimer's disease	0.00207	0.00459	CcSEcCtD
Canagliflozin—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00205	0.00453	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00202	0.00448	CcSEcCtD
Canagliflozin—Dry mouth—Galantamine—Alzheimer's disease	0.00199	0.00441	CcSEcCtD
Canagliflozin—Shock—Galantamine—Alzheimer's disease	0.00192	0.00425	CcSEcCtD
Canagliflozin—Nervous system disorder—Galantamine—Alzheimer's disease	0.00191	0.00424	CcSEcCtD
Canagliflozin—Urinary tract disorder—Memantine—Alzheimer's disease	0.00191	0.00423	CcSEcCtD
Canagliflozin—Skin disorder—Galantamine—Alzheimer's disease	0.00189	0.0042	CcSEcCtD
Canagliflozin—Urethral disorder—Memantine—Alzheimer's disease	0.00189	0.0042	CcSEcCtD
Canagliflozin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00187	0.00414	CcSEcCtD
Canagliflozin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00185	0.00411	CcSEcCtD
Canagliflozin—Erythema—Donepezil—Alzheimer's disease	0.00185	0.0041	CcSEcCtD
Canagliflozin—Malnutrition—Donepezil—Alzheimer's disease	0.00185	0.0041	CcSEcCtD
Canagliflozin—Hypotension—Galantamine—Alzheimer's disease	0.00182	0.00404	CcSEcCtD
Canagliflozin—Angiopathy—Memantine—Alzheimer's disease	0.00175	0.00388	CcSEcCtD
Canagliflozin—Angiopathy—Rivastigmine—Alzheimer's disease	0.00171	0.0038	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00168	0.00373	CcSEcCtD
Canagliflozin—Malnutrition—Memantine—Alzheimer's disease	0.00168	0.00373	CcSEcCtD
Canagliflozin—Fatigue—Galantamine—Alzheimer's disease	0.00168	0.00373	CcSEcCtD
Canagliflozin—Constipation—Galantamine—Alzheimer's disease	0.00167	0.0037	CcSEcCtD
Canagliflozin—Syncope—Donepezil—Alzheimer's disease	0.00166	0.00368	CcSEcCtD
Canagliflozin—Erythema—Rivastigmine—Alzheimer's disease	0.00164	0.00365	CcSEcCtD
Canagliflozin—Malnutrition—Rivastigmine—Alzheimer's disease	0.00164	0.00365	CcSEcCtD
Canagliflozin—Loss of consciousness—Donepezil—Alzheimer's disease	0.00163	0.00361	CcSEcCtD
Canagliflozin—Convulsion—Donepezil—Alzheimer's disease	0.0016	0.00356	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00159	0.00353	CcSEcCtD
Canagliflozin—Dry mouth—Donepezil—Alzheimer's disease	0.00154	0.00342	CcSEcCtD
Canagliflozin—Abdominal pain—Galantamine—Alzheimer's disease	0.00154	0.00342	CcSEcCtD
Canagliflozin—Syncope—Memantine—Alzheimer's disease	0.00151	0.00334	CcSEcCtD
Canagliflozin—Infection—Donepezil—Alzheimer's disease	0.0015	0.00333	CcSEcCtD
Canagliflozin—Shock—Donepezil—Alzheimer's disease	0.00149	0.0033	CcSEcCtD
Canagliflozin—Nervous system disorder—Donepezil—Alzheimer's disease	0.00148	0.00329	CcSEcCtD
Canagliflozin—Loss of consciousness—Memantine—Alzheimer's disease	0.00148	0.00328	CcSEcCtD
Canagliflozin—Syncope—Rivastigmine—Alzheimer's disease	0.00148	0.00327	CcSEcCtD
Canagliflozin—Convulsion—Memantine—Alzheimer's disease	0.00146	0.00323	CcSEcCtD
Canagliflozin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00145	0.0032	CcSEcCtD
Canagliflozin—Hypersensitivity—Galantamine—Alzheimer's disease	0.00144	0.00318	CcSEcCtD
Canagliflozin—Convulsion—Rivastigmine—Alzheimer's disease	0.00143	0.00316	CcSEcCtD
Canagliflozin—Hypotension—Donepezil—Alzheimer's disease	0.00141	0.00313	CcSEcCtD
Canagliflozin—Dry mouth—Memantine—Alzheimer's disease	0.0014	0.0031	CcSEcCtD
Canagliflozin—Asthenia—Galantamine—Alzheimer's disease	0.0014	0.0031	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00139	0.00308	CcSEcCtD
Canagliflozin—Dry mouth—Rivastigmine—Alzheimer's disease	0.00137	0.00304	CcSEcCtD
Canagliflozin—Infection—Memantine—Alzheimer's disease	0.00136	0.00302	CcSEcCtD
Canagliflozin—Shock—Memantine—Alzheimer's disease	0.00135	0.00299	CcSEcCtD
Canagliflozin—Nervous system disorder—Memantine—Alzheimer's disease	0.00135	0.00298	CcSEcCtD
Canagliflozin—Infection—Rivastigmine—Alzheimer's disease	0.00133	0.00296	CcSEcCtD
Canagliflozin—Skin disorder—Memantine—Alzheimer's disease	0.00133	0.00295	CcSEcCtD
Canagliflozin—Shock—Rivastigmine—Alzheimer's disease	0.00132	0.00293	CcSEcCtD
Canagliflozin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00132	0.00292	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0013	0.00289	CcSEcCtD
Canagliflozin—Skin disorder—Rivastigmine—Alzheimer's disease	0.0013	0.00289	CcSEcCtD
Canagliflozin—Fatigue—Donepezil—Alzheimer's disease	0.0013	0.00289	CcSEcCtD
Canagliflozin—Constipation—Donepezil—Alzheimer's disease	0.00129	0.00286	CcSEcCtD
Canagliflozin—Dizziness—Galantamine—Alzheimer's disease	0.00129	0.00286	CcSEcCtD
Canagliflozin—Hypotension—Memantine—Alzheimer's disease	0.00128	0.00284	CcSEcCtD
Canagliflozin—Hypotension—Rivastigmine—Alzheimer's disease	0.00125	0.00278	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00124	0.00274	CcSEcCtD
Canagliflozin—Rash—Galantamine—Alzheimer's disease	0.00123	0.00273	CcSEcCtD
Canagliflozin—Dermatitis—Galantamine—Alzheimer's disease	0.00123	0.00272	CcSEcCtD
Canagliflozin—Urticaria—Donepezil—Alzheimer's disease	0.0012	0.00266	CcSEcCtD
Canagliflozin—Abdominal pain—Donepezil—Alzheimer's disease	0.00119	0.00265	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00118	0.00263	CcSEcCtD
Canagliflozin—Fatigue—Memantine—Alzheimer's disease	0.00118	0.00262	CcSEcCtD
Canagliflozin—Constipation—Memantine—Alzheimer's disease	0.00117	0.0026	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00257	CcSEcCtD
Canagliflozin—Nausea—Galantamine—Alzheimer's disease	0.00116	0.00257	CcSEcCtD
Canagliflozin—Fatigue—Rivastigmine—Alzheimer's disease	0.00116	0.00257	CcSEcCtD
Canagliflozin—Constipation—Rivastigmine—Alzheimer's disease	0.00115	0.00254	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00112	0.00249	CcSEcCtD
Canagliflozin—Hypersensitivity—Donepezil—Alzheimer's disease	0.00111	0.00247	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.0011	0.00243	CcSEcCtD
Canagliflozin—Urticaria—Memantine—Alzheimer's disease	0.00109	0.00242	CcSEcCtD
Canagliflozin—Abdominal pain—Memantine—Alzheimer's disease	0.00108	0.0024	CcSEcCtD
Canagliflozin—Asthenia—Donepezil—Alzheimer's disease	0.00108	0.0024	CcSEcCtD
Canagliflozin—Pruritus—Donepezil—Alzheimer's disease	0.00107	0.00237	CcSEcCtD
Canagliflozin—Urticaria—Rivastigmine—Alzheimer's disease	0.00107	0.00236	CcSEcCtD
Canagliflozin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00106	0.00235	CcSEcCtD
Canagliflozin—Hypersensitivity—Memantine—Alzheimer's disease	0.00101	0.00224	CcSEcCtD
Canagliflozin—Dizziness—Donepezil—Alzheimer's disease	0.000999	0.00222	CcSEcCtD
Canagliflozin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000989	0.00219	CcSEcCtD
Canagliflozin—Asthenia—Memantine—Alzheimer's disease	0.000985	0.00218	CcSEcCtD
Canagliflozin—Pruritus—Memantine—Alzheimer's disease	0.000971	0.00215	CcSEcCtD
Canagliflozin—Asthenia—Rivastigmine—Alzheimer's disease	0.000963	0.00213	CcSEcCtD
Canagliflozin—Rash—Donepezil—Alzheimer's disease	0.000953	0.00211	CcSEcCtD
Canagliflozin—Dermatitis—Donepezil—Alzheimer's disease	0.000952	0.00211	CcSEcCtD
Canagliflozin—Pruritus—Rivastigmine—Alzheimer's disease	0.00095	0.00211	CcSEcCtD
Canagliflozin—Dizziness—Memantine—Alzheimer's disease	0.000907	0.00201	CcSEcCtD
Canagliflozin—Nausea—Donepezil—Alzheimer's disease	0.000898	0.00199	CcSEcCtD
Canagliflozin—Dizziness—Rivastigmine—Alzheimer's disease	0.000888	0.00197	CcSEcCtD
Canagliflozin—Rash—Memantine—Alzheimer's disease	0.000865	0.00192	CcSEcCtD
Canagliflozin—Dermatitis—Memantine—Alzheimer's disease	0.000864	0.00192	CcSEcCtD
Canagliflozin—Rash—Rivastigmine—Alzheimer's disease	0.000846	0.00188	CcSEcCtD
Canagliflozin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000846	0.00187	CcSEcCtD
Canagliflozin—Nausea—Memantine—Alzheimer's disease	0.000815	0.00181	CcSEcCtD
Canagliflozin—Nausea—Rivastigmine—Alzheimer's disease	0.000797	0.00177	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—CAV1—Alzheimer's disease	0.000123	0.00051	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000121	0.000503	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000121	0.000502	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.00012	0.000499	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000118	0.000491	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—TGFB1—Alzheimer's disease	0.000117	0.000486	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000114	0.000474	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—LPL—Alzheimer's disease	0.000114	0.000474	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—TGFB1—Alzheimer's disease	0.000114	0.000474	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	0.000113	0.000469	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	0.000113	0.000468	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CLU—Alzheimer's disease	0.000113	0.000467	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000111	0.000462	CbGpPWpGaD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000111	0.000461	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS3—Alzheimer's disease	0.000111	0.00046	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS3—Alzheimer's disease	0.000111	0.00046	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.00011	0.000458	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DHCR24—Alzheimer's disease	0.00011	0.000456	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	0.000108	0.000448	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PPARG—Alzheimer's disease	0.000108	0.000448	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PPARG—Alzheimer's disease	0.000108	0.000448	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—Alzheimer's disease	0.000108	0.000448	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.000107	0.000444	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—INS—Alzheimer's disease	0.000106	0.00044	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—INS—Alzheimer's disease	0.000106	0.00044	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000105	0.000435	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000104	0.000433	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000104	0.00043	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000103	0.000427	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	0.000103	0.000427	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MTHFR—Alzheimer's disease	0.000103	0.000427	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000103	0.000426	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000103	0.000425	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—Alzheimer's disease	0.000101	0.000421	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—Alzheimer's disease	0.000101	0.000421	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000101	0.00042	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—A2M—Alzheimer's disease	0.0001	0.000417	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	9.91e-05	0.000411	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DHCR24—Alzheimer's disease	9.63e-05	0.0004	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	9.63e-05	0.0004	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CALM1—Alzheimer's disease	9.61e-05	0.000399	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APOE—Alzheimer's disease	9.57e-05	0.000397	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	9.56e-05	0.000397	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—Alzheimer's disease	9.52e-05	0.000395	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.49e-05	0.000394	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CAV1—Alzheimer's disease	9.49e-05	0.000394	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	9.44e-05	0.000392	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CA4—Alzheimer's disease	9.35e-05	0.000388	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NOS3—Alzheimer's disease	9.29e-05	0.000386	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NOS3—Alzheimer's disease	9.29e-05	0.000386	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	9.14e-05	0.000379	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	8.91e-05	0.00037	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GAPDHS—Alzheimer's disease	8.79e-05	0.000365	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	8.77e-05	0.000364	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TPI1—Alzheimer's disease	8.72e-05	0.000362	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CHAT—Alzheimer's disease	8.72e-05	0.000362	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—Alzheimer's disease	8.71e-05	0.000362	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	8.69e-05	0.000361	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—INPP5D—Alzheimer's disease	8.63e-05	0.000358	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	8.58e-05	0.000356	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TF—Alzheimer's disease	8.53e-05	0.000354	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—Alzheimer's disease	8.5e-05	0.000353	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—Alzheimer's disease	8.5e-05	0.000353	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	8.37e-05	0.000347	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MAOB—Alzheimer's disease	8.36e-05	0.000347	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	8.34e-05	0.000346	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—Alzheimer's disease	8.34e-05	0.000346	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ATP5A1—Alzheimer's disease	8.33e-05	0.000346	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	8.19e-05	0.00034	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CA4—Alzheimer's disease	8.19e-05	0.00034	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—INS—Alzheimer's disease	8.18e-05	0.000339	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GAPDH—Alzheimer's disease	8.05e-05	0.000334	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.96e-05	0.00033	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLD3—Alzheimer's disease	7.95e-05	0.00033	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.95e-05	0.00033	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.88e-05	0.000327	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.86e-05	0.000326	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—GAB2—Alzheimer's disease	7.8e-05	0.000324	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—A2M—Alzheimer's disease	7.77e-05	0.000323	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	7.7e-05	0.00032	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HSD17B10—Alzheimer's disease	7.62e-05	0.000316	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.61e-05	0.000316	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—APP—Alzheimer's disease	7.61e-05	0.000316	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	7.51e-05	0.000312	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.45e-05	0.000309	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.39e-05	0.000307	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP46A1—Alzheimer's disease	7.34e-05	0.000304	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	7.33e-05	0.000304	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFB1—Alzheimer's disease	7.33e-05	0.000304	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFB1—Alzheimer's disease	7.33e-05	0.000304	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	7.3e-05	0.000303	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	7.22e-05	0.0003	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NOS3—Alzheimer's disease	7.17e-05	0.000298	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ND1—Alzheimer's disease	7.08e-05	0.000294	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	7.04e-05	0.000292	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLD3—Alzheimer's disease	6.96e-05	0.000289	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.93e-05	0.000288	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.92e-05	0.000287	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	6.92e-05	0.000287	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ACHE—Alzheimer's disease	6.76e-05	0.000281	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—INPP5D—Alzheimer's disease	6.68e-05	0.000277	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	6.68e-05	0.000277	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—Alzheimer's disease	6.56e-05	0.000272	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.47e-05	0.000269	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	6.43e-05	0.000267	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS1—Alzheimer's disease	6.34e-05	0.000263	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ENO1—Alzheimer's disease	6.34e-05	0.000263	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.33e-05	0.000263	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	6.3e-05	0.000262	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2D6—Alzheimer's disease	6.21e-05	0.000258	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ND1—Alzheimer's disease	6.21e-05	0.000258	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SOD1—Alzheimer's disease	6.2e-05	0.000257	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	5.99e-05	0.000249	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.93e-05	0.000246	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—BCHE—Alzheimer's disease	5.89e-05	0.000244	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF2—Alzheimer's disease	5.89e-05	0.000244	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	5.56e-05	0.000231	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLCB1—Alzheimer's disease	5.56e-05	0.000231	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—Alzheimer's disease	5.53e-05	0.000229	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—Alzheimer's disease	5.53e-05	0.000229	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.46e-05	0.000227	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.45e-05	0.000226	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCA1—Alzheimer's disease	5.39e-05	0.000224	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PRKCG—Alzheimer's disease	5.31e-05	0.00022	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.17e-05	0.000214	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.11e-05	0.000212	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—AKT1—Alzheimer's disease	5.1e-05	0.000212	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—AKT1—Alzheimer's disease	5.1e-05	0.000212	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CA4—Alzheimer's disease	5.05e-05	0.000209	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.97e-05	0.000206	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	4.79e-05	0.000199	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.74e-05	0.000197	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.72e-05	0.000196	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARGC1A—Alzheimer's disease	4.64e-05	0.000193	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PLAU—Alzheimer's disease	4.64e-05	0.000193	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HMOX1—Alzheimer's disease	4.62e-05	0.000192	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CALM1—Alzheimer's disease	4.59e-05	0.000191	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TPI1—Alzheimer's disease	4.57e-05	0.000189	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CHAT—Alzheimer's disease	4.57e-05	0.000189	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CAV1—Alzheimer's disease	4.53e-05	0.000188	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.53e-05	0.000188	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.5e-05	0.000187	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	4.4e-05	0.000183	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MAOB—Alzheimer's disease	4.38e-05	0.000182	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.33e-05	0.00018	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—F2—Alzheimer's disease	4.31e-05	0.000179	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.29e-05	0.000178	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AKT1—Alzheimer's disease	4.27e-05	0.000177	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AKT1—Alzheimer's disease	4.27e-05	0.000177	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS2—Alzheimer's disease	4.26e-05	0.000177	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LPL—Alzheimer's disease	4.23e-05	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GAPDH—Alzheimer's disease	4.21e-05	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.17e-05	0.000173	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.13e-05	0.000171	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.11e-05	0.000171	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—A2M—Alzheimer's disease	4.07e-05	0.000169	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.04e-05	0.000168	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CHAT—Alzheimer's disease	4e-05	0.000166	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TPI1—Alzheimer's disease	4e-05	0.000166	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.96e-05	0.000164	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MAOB—Alzheimer's disease	3.83e-05	0.000159	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.82e-05	0.000159	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	3.81e-05	0.000158	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF1—Alzheimer's disease	3.78e-05	0.000157	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GAPDH—Alzheimer's disease	3.69e-05	0.000153	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.63e-05	0.000151	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—A2M—Alzheimer's disease	3.57e-05	0.000148	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.56e-05	0.000148	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CALM1—Alzheimer's disease	3.56e-05	0.000148	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOE—Alzheimer's disease	3.54e-05	0.000147	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ACHE—Alzheimer's disease	3.54e-05	0.000147	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAV1—Alzheimer's disease	3.51e-05	0.000146	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—INPP5D—Alzheimer's disease	3.5e-05	0.000145	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—Alzheimer's disease	3.43e-05	0.000142	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS1—Alzheimer's disease	3.32e-05	0.000138	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ENO1—Alzheimer's disease	3.32e-05	0.000138	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AKT1—Alzheimer's disease	3.3e-05	0.000137	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2D6—Alzheimer's disease	3.25e-05	0.000135	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ACHE—Alzheimer's disease	3.1e-05	0.000129	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—Alzheimer's disease	3.09e-05	0.000128	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BCHE—Alzheimer's disease	3.08e-05	0.000128	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—INPP5D—Alzheimer's disease	3.07e-05	0.000127	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	3.06e-05	0.000127	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—INS—Alzheimer's disease	3.03e-05	0.000126	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.01e-05	0.000125	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLCB1—Alzheimer's disease	2.91e-05	0.000121	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.91e-05	0.000121	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.91e-05	0.000121	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.85e-05	0.000118	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.85e-05	0.000118	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCA1—Alzheimer's disease	2.82e-05	0.000117	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.7e-05	0.000112	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—Alzheimer's disease	2.65e-05	0.00011	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.55e-05	0.000106	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.47e-05	0.000103	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—Alzheimer's disease	2.47e-05	0.000102	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.46e-05	0.000102	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.46e-05	0.000102	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARGC1A—Alzheimer's disease	2.43e-05	0.000101	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	2.43e-05	0.000101	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMOX1—Alzheimer's disease	2.42e-05	0.0001	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.36e-05	9.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.27e-05	9.44e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—Alzheimer's disease	2.27e-05	9.41e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPL—Alzheimer's disease	2.21e-05	9.19e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.2e-05	9.12e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.13e-05	8.84e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.12e-05	8.8e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—Alzheimer's disease	1.99e-05	8.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPL—Alzheimer's disease	1.94e-05	8.05e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.91e-05	7.93e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.89e-05	7.84e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—Alzheimer's disease	1.87e-05	7.74e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CALM1—Alzheimer's disease	1.86e-05	7.73e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOE—Alzheimer's disease	1.86e-05	7.7e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAV1—Alzheimer's disease	1.84e-05	7.63e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.79e-05	7.43e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.79e-05	7.43e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.76e-05	7.29e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.75e-05	7.25e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.66e-05	6.91e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.63e-05	6.77e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOE—Alzheimer's disease	1.63e-05	6.75e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—Alzheimer's disease	1.62e-05	6.71e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.61e-05	6.68e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—INS—Alzheimer's disease	1.58e-05	6.58e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT1—Alzheimer's disease	1.58e-05	6.54e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.57e-05	6.52e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.52e-05	6.32e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.42e-05	5.88e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—Alzheimer's disease	1.39e-05	5.77e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—INS—Alzheimer's disease	1.39e-05	5.76e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.31e-05	5.45e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.31e-05	5.42e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—Alzheimer's disease	1.27e-05	5.28e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AKT1—Alzheimer's disease	1.22e-05	5.06e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.22e-05	5.05e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.19e-05	4.96e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.11e-05	4.62e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.08e-05	4.46e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1e-05	4.17e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOE—Alzheimer's disease	1e-05	4.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.92e-06	4.12e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.72e-06	3.62e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—INS—Alzheimer's disease	8.55e-06	3.55e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.5e-06	3.11e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.86e-06	2.85e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKT1—Alzheimer's disease	6.39e-06	2.65e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.6e-06	2.32e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.45e-06	1.43e-05	CbGpPWpGaD
